HANNAH HAZLEWOOD: Open Payments
NPI 1851929335 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,380 in 123 payments from 16 companies in 2025. Trend: 2023 $793 · 2024 $1,772 · 2025 $2,380
Food & beverage: $2,180Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $328 |
| UCB, Inc. | 14 | $285 |
| Novartis Pharmaceuticals Corporation | 14 | $273 |
| Lilly USA, LLC | 17 | $261 |
| ABBVIE INC. | 18 | $218 |
| GENZYME CORPORATION | 6 | $190 |
| Galderma Laboratories, L.P. | 14 | $178 |
| Incyte Corporation | 5 | $119 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $112 |
Products named: TREMFYA, DUPIXENT, Bimzelx, EBGLYSS, SKYRIZI, NEMLUVIO, OPZELURA, COSENTYX.
Industry payments across IN — which companies pay providers there.
